Market Analysis & Manufactures

By bacteria like E.coli, Salmonella, H.pylori, N.gonorrhoeae, N.meningitidis, S.aureus, and S.bacteria. It includes diseases like pneumonia, meningitis, gastroenteritis, urinary tract infections. Case Reports in Clinical Pathology and industrial microbiology supports the diagnosis of disease using laboratory testing of blood, tissues, and other body fluids. There are types of specimens used clinical pathology. They are blood, urine, sputum, faeces, and other body fluids. It deals with women's complaints gynaecological diseases, fertility, pregnancy.

 The drugs used to treat such bacterial infections are called Antibiotics. Especially in US about $ 44.68 billion is expected to reach by 2016.In the period of 2005-2011, there is a growth rate of 6.6% annually. The manufacturing of antibiotics has increased gradually these days, so global demand for aminoglycoside antibiotics is about 79%, pencillin 8%, tetracyclines 4%, erythromycin 7%, streptomycin 1% and chloramphenicol shares about 1% in the antibiotic market globally. Certain bacteria provide benefits to plant including tolerance to temperature stress, salty soils, drought etc. so, there developed microbial seed and plan treatments to confer these stress conditions. It was reported that seed treatment market is trying to reach $ 6 billion by 2020 as it used to be $ 3.6 billion in 2003.

The consumables, equipment and technology markets in the industrial bacteriology and Microbiology industry comes around nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018.

  • Innovative vaccine manufacturing technologies using bioreactors
  • Case reports from vaccine Manufacturers
  • Review and debate on latest discoveries in Bacteriology

Related Conference of Market Analysis & Manufactures

Market Analysis & Manufactures Conference Speakers